<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Insight数据库 | wechat-feeds</title><link>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</link><description>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 02 Mar 2021 20:33:16 +0800</pubDate><image><url>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</url><title>Insight数据库 | wechat-feeds</title><link>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>晚期肝癌，指南推荐了这些靶向药和免疫疗法</title><link>https://mp.weixin.qq.com/s/Lm0K2_yJJgsYj2kYZiXBZg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZaHmkHykcIpFQHDHp3DWfycBtE31TtkRnwmU7w47qWOxTs7qWuJ2wII3NbPicMmAEefdMA18j4GibWA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight 数据库]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:34:07 +0800</pubDate></item><item><title>获批一年半，默沙东宣布撤回 K 药小细胞肺癌适应症</title><link>https://mp.weixin.qq.com/s/pSXQ-D5ELUdP72Wv7tKZtA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYWmRmAzr1kqOfodGWD10U8ias590mEmEYztd1IrP5zicQUvvUMqSk3c5ZLInISnQGprFp97BXBT1Gg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:34:07 +0800</pubDate></item><item><title>信立泰质量负责人、副总经理赵万顺辞职，曾履职拜耳、扬子江等企业</title><link>https://mp.weixin.qq.com/s/O744gHb1x9nC7wavtUgk8w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYWmRmAzr1kqOfodGWD10U8I6pFfW8ACLPEusgkuyJ8z2Fk7ENhD3fXic5T02YRDf9cGvpwsMsU7AQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:34:07 +0800</pubDate></item><item><title>重磅：30亿+规模注射用头孢曲松钠首家新增适应症过评，金城金素强势来袭！</title><link>https://mp.weixin.qq.com/s/b2hY4qQRY8T6ERfTls_kLw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/8J9UGoucicIRvZVO5Hh8OTBLvKt19szicVsLAHzsrqKpBJdXpSf7GoETjXR4u7jjglz6P4qOCiadwx3AQJ5pMun7w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>重磅：30亿+规模注射用头孢曲松首家增适应症过评！！]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:34:07 +0800</pubDate></item><item><title>上市到进医保中位数 1.8 年！2020 医保目录正式执行，最全谈判价格曝光（附 Excel 下载）</title><link>https://mp.weixin.qq.com/s/ngvCHfM6_4X6VpK59Plj_g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZaHmkHykcIpFQHDHp3DWfyc6m3lg6bouqodibquGJdhGNff9klviaYD20INpSCr9DFzyPO1apFbNmWQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:58:12 +0800</pubDate></item><item><title>默沙东 CTLA-4 单抗国内获批临床，2 亿美元从康方生物引进</title><link>https://mp.weixin.qq.com/s/hlc6QKvYxhDPiulhL1UD4Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZaHmkHykcIpFQHDHp3DWfycvF9l6wocnycsIUgzCP6Bpg6GibYIKBiaIXMJdp9PbEtBPwlHmSh6E09w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:58:12 +0800</pubDate></item><item><title>百济神州 PD-1降价 80% 进医保，今日正式执行</title><link>https://mp.weixin.qq.com/s/Eugk-asqI8Em2zP_jb-81Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZaHmkHykcIpFQHDHp3DWfycbR3iaOrWiaia2XJcI8Ta3OuYCGXL8ib3HULiaFjDZ0KyYiac6nB5O3bDRk2g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:58:12 +0800</pubDate></item><item><title>复星医药高管变动！副总裁陈战宇离职，李东久继任</title><link>https://mp.weixin.qq.com/s/RhzIqrdfn4ABrWG2KAE3Gw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZaHmkHykcIpFQHDHp3DWfycoiao8FoquTAYgU0KSTvVOujODcnsaKCs05ztK3tKPq5E7tRfM0uVTOg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:58:12 +0800</pubDate></item><item><title>药研论坛｜药品注册现场核查及M4注册申报文件撰写与递交专题培训</title><link>https://mp.weixin.qq.com/s/pXkeGwmeWy9_emPEX5j46Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/icVUq9ICDeI1NHiaqP537zXOXia0EuEt6pHG4AlicshLQTko7ia7Gib3icr4ibjhbDPU54EKbVNjeWaXB3r7SwosiaRQpSQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2021年3月20~21（周六日）地点：南京曙光国际大酒店]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:58:12 +0800</pubDate></item><item><title>本周 25 个仿制药通过一致性评价，七成为注射剂</title><link>https://mp.weixin.qq.com/s/5iAwOwDNLFbIlk_t3Cm6jA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYQywZiatU7u6aiajTmw4ZbBK5PGHQPC4Z90zPw7wuRS0yroJjonaLwNFicTY34qCFLZ9kj6XztQk0Lg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Sun, 28 Feb 2021 03:36:29 +0800</pubDate></item><item><title>「治愈」癌症需百万，中国首个 CAR-T 药物或将上市</title><link>https://mp.weixin.qq.com/s/sKg9cEhNe6pUjaQo3IM9-w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYQywZiatU7u6aiajTmw4ZbBKfWx20FH5mWhcI5zqgb859yr7U3Z9RpzwuOpKnianTJNVnc7gNAXOdag/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>这款新药，可能「治愈」也可能「杀死」一名无药可用的癌症患者，怎么选？]]></content:encoded><pubDate>Fri, 26 Feb 2021 18:34:40 +0800</pubDate></item><item><title>百奥泰 2020 业绩快报：阿达木单抗销售额 1.83 亿元</title><link>https://mp.weixin.qq.com/s/Sw140EHmTHmWf0nEaV0Ceg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYQywZiatU7u6aiajTmw4ZbBKyOlw0hYwWLVdNMDx5JQUQibUICUjWqeic7sRI1CvF28jbB65N4DfJjBQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight 数据库]]></content:encoded><pubDate>Fri, 26 Feb 2021 18:34:40 +0800</pubDate></item><item><title>PD-1 销售额 1.63 亿美元，亏损增至 16 亿美元！百济神州为何依然被看好？</title><link>https://mp.weixin.qq.com/s/DF-HycaByAjR6wIweJhbrQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYQywZiatU7u6aiajTmw4ZbBKSKSw0n10QMx18Lk7OkDzzDF6DsPYvNLzmycxRlRzwSzicF2UnDYFLmQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:46:14 +0800</pubDate></item><item><title>药圈灯谜会，能猜出来我服你！</title><link>https://mp.weixin.qq.com/s/eoCZw4PGXFqhTuHwr1AW7Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZah1cPDPiabND45fF2QOQ28syxWeqxyWLhJUPmrIWYlwUQggc5PSND5Hr0RoGByjuxJP4xHEaAGsWA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药圈灯谜会来了~]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:46:14 +0800</pubDate></item><item><title>君实生物业绩快报：营收 15.95 亿元，亏损 16.72 亿元</title><link>https://mp.weixin.qq.com/s/RdCNw_mkY6mHs529dudzAw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYQywZiatU7u6aiajTmw4ZbBKDz1B9K2re6937INeESSkHMarqHHLUGaS07QrkyKVICxIBJmC8fyYtA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight 数据库]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:46:14 +0800</pubDate></item><item><title>首个 Opdivo 生物类似药，绿叶制药 LY01015 临床申请获受理</title><link>https://mp.weixin.qq.com/s/hWyZvnZ8nXrQzcvCVy1j9w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYQywZiatU7u6aiajTmw4ZbBK8qnlSTrhyfpcacwPvxudftkHutiaz3p8c0XiaKJicDp4mcHt33y8DBNLA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight 数据库]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:46:14 +0800</pubDate></item><item><title>议程公开|50+化学领袖深度探讨小分子新药开发新进展、战略趋势与投资热点、MAH制度与策略管理，PIM2021邀您3月聚首杭州！</title><link>https://mp.weixin.qq.com/s/uf63ZSSqZg_shcrZ1gTXEQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Ivoyg91aXs2pYJ2WFEJTcsHdQooeB1DfKamVibxKxY4BI1beHhZwR4SrFmWGbwFq31JgoeGRoCdcoapFf5bxicUg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>将于3月30-31日在杭州逐梦起航！]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:46:14 +0800</pubDate></item><item><title>一致性评价，这 16 家药企开始了（附名单）</title><link>https://mp.weixin.qq.com/s/BQqk6Ny3Ld0zSSaKnR3Sxw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYB6wZEkfNw28uMpzSWHEYg1iczKyAyiaM81krf38pJZpNjDH6rHvvf6nd6vwW71Fdgs7Jn5pA5bZGA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>丁香园 Insight 数据库]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:31:14 +0800</pubDate></item><item><title>累计投入 1.5 亿，恒瑞 PD-L1/TGFβ 双抗获批临床，广泛期小细胞肺癌</title><link>https://mp.weixin.qq.com/s/1hZumH0DX2ZB34EugJrQ_Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYB6wZEkfNw28uMpzSWHEYgsjjP0zchfX2wSHWMOMiclgznhXRIp5UVHsMlUeUdm3ibU6uct7lqM1og/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>丁香园 Insight 数据库]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:31:14 +0800</pubDate></item><item><title>贝达药业第四代 EGFR 抑制剂获批临床</title><link>https://mp.weixin.qq.com/s/sMwmVWIQh1i9RrAdx7cuMQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYB6wZEkfNw28uMpzSWHEYgHcONab320iaSNldMBKR8PKbyYCG0RxXBbyO7sicbib9QS3IURrSPbJw4g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Thu, 25 Feb 2021 18:31:14 +0800</pubDate></item></channel></rss>